Author

H. Semiz

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Prognostic Value of the Lung Immune Prognostic Index in Metastatic Renal Cell Carcinoma: A Multicentre Cohort Study

Background and Purpose: The Lung Immune Prognostic Index (LIPI), based on derived neutrophil-to-lymphocyte ratio (dNLR) and Lactate Dehydrogenase (LDH), is a recognized biomarker in various malignancies. However, its incremental value over the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) sco...

Savaş Gökçek, Mehmet Uzun, F. Özalp et al. · Journal of Basic and Clinica... · 0 citations

Open access Aug 2026

Clinicopathological features and survival of early-onset colon cancer: a SEER-based analysis of 156,031 curative-intent surgical patients

Aims: To analyze the clinicopathological features and survival outcomes of early-onset colon cancer (EOCC,

F. Özalp, Özge Yetginoğlu, Şerife Sivridemir et al. · Journal of Medicine and Pall... · 0 citations

Open access Sep 2026

Baseline Inflammatory and Nutritional Indices Show Limited Discrimination for Major Pathological Response and Survival After Neoadjuvant Chemotherapy for Gastric Cancer: A Retrospective Comparison of Eleven Indices

Background/Objectives: While perioperative chemotherapy is standard for locally advanced gastric cancer, no baseline blood marker reliably identifies which patients will respond to treatment. In this retrospective study, we compared eleven inflammatory and nutritional indices against pathological response and survival...

Erkut Demirciler, K. Canaslan, H. I. Ellez et al. · Journal of Clinical Medicine · 0 citations

Open access Aug 2026

Preoperative Prediction of Residual Cancer Burden After Neoadjuvant Chemotherapy in Breast Cancer: A Multimodal Machine Learning Approach and Implications for Clinical Decision Support

Background. Residual cancer burden (RCB) after neoadjuvant chemotherapy (NAC) offers finer prognostic stratification than binary pathologic complete response, and increasingly guides adjuvant treatment intensity. Predicting four-tier RCB class from preoperative data could inform adjuvant planning before surgery, yet th...

Y. K. Dagdeviren, H. Semiz, E. H. İnan et al. · medRxiv · 0 citations